The FTC cleared Amgen’s $27.8 billion Horizon buyout — here’s what it means for other massive pharma deals

[ad_1] Robert Galbraith | Reuters The Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement –  a…

Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle

[ad_1] The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims of six states that…

FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics

[ad_1] The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. [ad_2] Source link

FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics

[ad_1] An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo Acquire Licensing Rights Aug 26 (Reuters) – The U.S.…